ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript
ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc.
Stay updated with breaking news from Brett Sandercock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc.
River Wealth Advisors LLC cut its holdings in ResMed Inc. (NYSE:RMD – Free Report) by 3.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,097 shares of the medical equipment provider’s stock after selling 74 shares during the period. River Wealth Advisors LLC’s holdings in ResMed […]
PNC Financial Services Group Inc. lessened its position in shares of ResMed Inc. (NYSE:RMD – Free Report) by 6.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 92,385 shares of the medical equipment provider’s stock after selling 6,464 shares […]
ResMed (NYSE: RMD) recently received a number of ratings updates from brokerages and research firms: 2/6/2024 – ResMed is now covered by analysts at KeyCorp. They set an “overweight” rating and a $227.00 price target on the stock. 1/30/2024 – ResMed had its price target raised by analysts at Oppenheimer Holdings Inc. from $185.00 to […]
Huntington National Bank increased its position in ResMed Inc. (NYSE:RMD – Free Report) by 10.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 1,676 shares of the medical equipment provider’s stock after purchasing an additional 152 shares during the period. Huntington National Bank’s holdings in ResMed were […]